Hormone therapy safe for women, study finds

Hormone therapy safe for women
The study showed treatment using a combination of hormones estradiol and drospirenone resulted in significant improvement in menopausal symptoms.

(Medical Xpress)—A new study has examined the cognitive effects of hormone therapy on memory, language and concentration in menopausal women.

A study, published in the Menopause journal, examined the effects of (HRT) E2D, which used a combination of hormones estradiol and drospirenone to treat women. Early postmenopausal women aged between 49 and 55 who had never used HRT were assessed over a six-month period.

The treatment resulted in significant improvement in menopausal symptoms including hot flushes, night sweats, and sexual function, and it lowered blood pressure and weight in comparison to those who were treated with an identical placebo.

The women also underwent cognitive assessment and were asked to perform during a brain-imaging (MRI) scan.

Estradiol, a form of oestrogen combined with drospirenone, a progestin, were found to have no effect on the of early postmenopausal women.

Professor Susan Davis, Director of the Women's Health Research Program in the Monash University School of Public Health and Preventive Medicine, said there had long been debate about the safety of hormone replacement therapies and the potential adverse effects on cognitive function in women.

"These findings are reassuring for women," Professor Davis said.

"We report, for the first time, that combined with estradiol has no overall effect on the cognitive performance of postmenopausal women examined over a 26-week period.

"Although hormone replacement therapy is no quick fix to the challenge of menopause, it does show that the E2D treatment can be useful in the overall management of menopause, and without adversely effecting cognitive ability."

Professor Davis said memory and mood complaints were frequent in women after menopause due to oestrogen deficiency, including a lack of clarity of thought and memory or word-finding difficulties.

add to favorites email to friend print save as pdf

Related Stories

Testosterone therapy improves memory in postmenopausal women

Jun 06, 2011

Post-menopausal women have better memory after daily treatment with a testosterone spray for six months, a new preliminary study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting ...

Recommended for you

Using computers to design drugs

12 hours ago

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

17 hours ago

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

New US restrictions on painkiller to take effect

Aug 21, 2014

The federal government is finalizing new restrictions on hundreds of medicines containing hydrocodone, the highly addictive painkiller that has grown into the most widely prescribed drug in the U.S.

User comments